Skip to content

Gas Usage for Those With COPD Who Experience Low Oxygen Levels During Activities Only

Ambulatory Gas Usage in Patients With COPD and Exertional Hypoxemia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00546299
Enrollment
27
Registered
2007-10-18
Start date
2003-02-28
Completion date
2005-12-31
Last updated
2024-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

Ambulatory oxygen therapy, COPD, exertional hypoxemia

Brief summary

Several studies have described the use of supplemental oxygen during exertion or activities of daily living (ambulatory oxygen) in study populations that have different characteristics. This report, based on specialized randomized controlled trials, characterizes ambulatory gas usage among patients with COPD who experience low oxygen levels during activities.

Interventions

DRUGoxygen

cylinder and concentrator, dosage to maintain SpO2 above 92%, used during exertion

Sponsors

University of Toronto
CollaboratorOTHER
McMaster University
CollaboratorOTHER
Ontario Ministry of Health and Long Term Care
CollaboratorOTHER_GOV
West Park Healthcare Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 100 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of COPD * dyspnea limiting daily activities * desaturation less than or equal to 88% for 2 continuous minutes during a room air six-minute walk test

Exclusion criteria

* less than or equal to 18 years old * those who met criteria for mortality reduction with long-term oxygen * those who received oxygen for palliative care or isolated nocturnal hypoxemia * those unable to complete the questionnaires or provide informed consent

Design outcomes

Primary

MeasureTime frame
gas usage2

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026